The Effects of Continuous In Vivo Administration of Nisin on Staphylococcus aureus Infection and Immune Response in Mice

Mucosal targeting of therapeutic molecules using genetically modified lactic acid bacteria: an update

(2013) Jean Guy LeBlanc et al.   FEMS MICROBIOLOGY LETTERS

Nisin F-loaded brushite bone cement prevented the growth of Staphylococcus aureus in vivo

(2012) A.D. van Staden et al.   JOURNAL OF APPLIED MICROBIOLOGY

Targeting diseases with genetically engineeredLactococcus lactisand its course towards medical translation

(2011) Julio Villatoro-Hernandez et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Immunomodulatory efficacy of nisin-a bacterial lantibiotic peptide

(2011) D. Begde et al.   JOURNAL OF PEPTIDE SCIENCE

Glutamate Decarboxylase-Mediated Nisin Resistance in Listeria monocytogenes

(2010) M. Begley et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

The ability of nisin F to control Staphylococcus aureus infection in the peritoneal cavity, as studied in mice

(2010) A.M. Brand et al.   LETTERS IN APPLIED MICROBIOLOGY

To protect peptide pharmaceuticals against peptidases

(2010) R. Rink et al.   JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS

Novel Mechanism for Nisin Resistance via Proteolytic Degradation of Nisin by the Nisin Resistance Protein NSR

(2009) Z. Sun et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Evaluation of Nisin F in the Treatment of Subcutaneous Skin Infections, as Monitored by Using a Bioluminescent Strain of Staphylococcus aureus

(2009) M. de Kwaadsteniet et al.   Probiotics and Antimicrobial Proteins

Nisin F in the treatment of respiratory tract infections caused byStaphylococcus aureus

(2008) M. De Kwaadsteniet et al.   LETTERS IN APPLIED MICROBIOLOGY